Companies › Cancer Innovation and Regulation Initiative

Cancer Innovation and Regulation Initiative

Nonprofit or advocacy group Healthcare

Cancer Innovation and Regulation Initiative is listed as a nonprofit or advocacy group in Healthcare. It has filed 2 comment letters on 2 proposed federal rules in 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Nonprofit or advocacy group
Industry
Healthcare
Comment letters
2
Rules commented on
2
First letter
2026-07-28
Latest letter
2026-09-02
Agencies most often
Centers for Medicare & Medicaid Services (1); Commodity Futures Trading Commission (1)

Activity by year

20262

Letters

2026

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-02

Prediction Markets; Public Interest Determinations

CFTC-2026-1189Commodity Futures Trading Commission · filed 2026-07-28 · filed as “Cancer Innovation and Regulation Initiative (Harvard Medical School)”